The loss of libido treatment market — pharmaceutical and hormonal therapies addressing hypoactive sexual desire disorder (HSDD) and related low sexual desire conditions in both women and men — has entered a genuinely active period of regulatory expansion after decades of comparative neglect, with the Loss of Libido Treatment Market reflecting a landscape newly reshaped by...